D'Silva Andrew J. 内部人交易：近期 SEC Form 4 交易
过去 18 个月，D'Silva Andrew J.（CIK 2083717）在 1 家公司共报告 9 笔 SEC Form 4 内部人交易（最近一笔 2026-10-02）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-10-02 | OptimizeRx Corp (OPRX) | Chief Business Officer | 卖出 | 414 | $3,473 |
| 2026-09-02 | OptimizeRx Corp (OPRX) | Chief Business Officer | 卖出 | 1,432 | $11,256 |
| 2026-08-24 | OptimizeRx Corp (OPRX) | Chief Business Officer | 买入 | 57,600 | $0 |
| 2026-08-24 | OptimizeRx Corp (OPRX) | Chief Business Officer | 卖出 | 1,243 | $9,584 |
| 2025-12-22 | OptimizeRx Corp (OPRX) | Chief Business Officer | 卖出 | 703 | $9,498 |
| 2025-12-15 | OptimizeRx Corp (OPRX) | Chief Business Officer | 卖出 | 868 | $12,178 |
| 2025-11-07 | OptimizeRx Corp (OPRX) | Chief Business Officer | 卖出 | 414 | $7,858 |
| 2025-11-07 | OptimizeRx Corp (OPRX) | Chief Business Officer | 卖出 | 794 | $14,888 |
| 2025-10-07 | OptimizeRx Corp (OPRX) | Chief Business Officer | 买入 | 10,417 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-10-02